Midterm experience with implantable cardioverter-defibrillators in children and young adults

Europace

Volumn 12, Issue 12, 2010, Pages 1732-1738

  Eliker, Alpay ^a   Olgun, Haim ^b   Karagoz, Tevfik ^c   Özer, Sema ^c   Özkutlu, Süheyla ^c   Alehan, Dursun ^c  

^a ACIBADEM UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Appropriate shock; Children; Implantable cardioverter defibrillator; Secondary prophylaxis; Sudden cardiac death

Indexed keywords

ION CHANNEL;

ADOLESCENT; ADULT; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; DEFIBRILLATOR; FEMALE; GROUPS BY AGE; HUMAN; MALE; MORTALITY; PACEMAKER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHOCK; T WAVE;

ADOLESCENT; ALGORITHMS; ARRHYTHMIAS, CARDIAC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FEMALE; HUMANS; MALE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649340158     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq340     Document Type: Article

References (33)

1. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 guidelines for device-based therapy ofcardiac rhythm abnormalities. Heart Rhythm 2008;5:e1-62.
2. Wever EF, Hauer RN, van Capelle FL, Tijssen JG, Crijns HJ, Algra A et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995;91: 2195-203.
3. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
4. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Defibrillator Study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071-8.
5. Ezekowitz JA, Armstrong PW, Mc Alister FA. Implantable cardioverter defibrilla-tors in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 2003;138:445-52.
6. European Heart Rhythm Association; Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Commit-tee for Practice Guidelines (Writing Committee to Develop Guidelines for Man-agement of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48:e247-346.
7. Kadish A, Quigg R, Schaechter A, Anderson KP, Estes M, Levine J. Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol 2000; 23:338-43.
8. Silka MJ, Kron J, Dunnigan A, Dick M 2nd. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electro-physiology Society. Circulation 1993;87:800-7.
9. Cesario DA, Dec GW. Implantable cardioverter-defibrillator therapy in clinical practice. J Am Coll Cardiol 2006;47:1507-17.
10. Blom NA. Implantable cardioverter-defibrillators in children. Pacing Clin Electro-physiol 2008;31(Suppl. 1):S32-4.
11. Gradaus R, Wollmann C, Kobe J, Hammel D, Kotthoff S, Block M et al. Potential benefit from implantable cardioverter-defibrillator therapy in children and young adolescents. Heart 2004;90:328-9.
12. Stefanelli CB, Bradley DJ, Leroy S, Dick M 2nd, Serwer GA, Fischbach PS. Implan-table cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol 2002;6:235-44.
13. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004;27: 924-32.
14. Ten Harkel ADJ, Blom NA, Reimer AG, Tukkie R, Sreeram N, Bink-Boelkens MT. Implantable cardioverter defibrillator implantation in children in the Netherlands. Eur J Pediatr 2005;164:436-41.
15. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008;51:1685-91.
16. Costa R, Silva KR, Mendonça RC, Nishioka SA, Siqueira Sde F, Tamaki WT et al. Incidence of shock and quality of life in young patients with implantable cardioverter-defibrillator. Arq Bras Cardiol 2007;88:258-64.
17. Eicken A, Kolb C, Lange S, Brodherr-Heberlein S, Zrenner B, Schreiber C et al. Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol 2006;107: 30-5.
18. Botsch MP, Franzbach B, Opgen-Rhein B, Berger F, Will JC. ICD therapy in children and young adults: low incidence of inappropriate shock delivery. Pacing Clin Electrophysiol 2010;33:734-41.
19. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventriculartachycardia in children. A 7-yearfollow-up of21 patients. Circulation 1995;91:1512-9.
20. Lucet V, Grau F, Denjoy I, Do Ngoc D, Geiger K, Ghisla R et al. Long term course ofcatecholaminergic polymorphic ventricular tachycardia in children. Apropos of 20 cases with an 8 year-follow-up. Arch Pediatr 1994;1:26-32 [Abstract].
21. Celiker A, Erdogan I, Karagöz T, Ozer S. Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia. Cardiol Young 2009;19: 45-52.
22. Goel AK, Berger S, Pelech A, Dhala A. Implantable cardioverter defibrillator therapy in children with long QT syndrome. Pediatr Cardiol 2004;25:370-8.
23. Grimm W, Hoffmann J, Muller HH, Maisch B. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol 2002;39:780-7.
24. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFI-NITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006;113:776-82.
25. Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, Mc Kenna WJ. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hyper-trophic cardiomyopathy. J Am Coll Cardiol 1999;33:1596-601.
26. Hauer RNW, Aliot E, Block M, Capucci A, Luderitz B, Santini M et al. Indications for implantable cardioverter defibrillator (ICD) therapy. Eur Heart J 2001;22: 1074-81.
27. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998;32:245-51.
28. Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol 1996;77:524-6.
29. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004;15:72-6.
30. Pablo Kaski J, Tomé Esteban MT, Lowe M, Sporton S, Rees P, Deanfield JE et al.Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy. Heart 2007;93:372-4.
31. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006;17:41-6.
32. Link MS, Hill SL, Cliff DL, Swygman CA, Foote CB, Homoud MK. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol 1999;83:263-6.
33. Olgun H, Karagoz T, Celiker A, Ceviz N. Patient-and lead-related factors affecting lead fracture in children with transvenous permanent pacemaker. Europace 2008; 10:844-7.